Insulet (PODD) Total Non-Current Liabilities (2010 - 2026)

Insulet (PODD) posted Total Non-Current Liabilities of $1.6 billion for Q1 2026, little changed on a QoQ basis from $1.6 billion in Q4 2025, and down 24.19% year-over-year from $2.1 billion in Q1 2025.

Insulet (PODD) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Insulet's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 24.19% year-over-year to $1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (down 24.19% YoY) and the FY2025 annual result came in at $1.6 billion, down 11.71% from the prior year.
  • Total Non-Current Liabilities was $1.6 billion for Q1 2026 at Insulet, roughly flat from $1.6 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.1 billion in Q1 2025 and bottomed at $1.6 billion in Q3 2025.
  • A 5-year average of $1.8 billion and a median of $1.8 billion in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities rose 29.78% — and 2026, when it declined 24.19%.
  • Insulet's Total Non-Current Liabilities stood at $1.7 billion in 2022, then gained by 4.52% to $1.8 billion in 2023, then climbed by 0.37% to $1.8 billion in 2024, then retreated by 11.71% to $1.6 billion in 2025, then gained by 0.38% to $1.6 billion in 2026.
  • Business Quant data shows PODD's Total Non-Current Liabilities at $1.6 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 20.94 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 2.64 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 3.53 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 24.21 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 3.57 Bn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 9.85 Bn
10 Insulet 11.52 Bn 11.04 Bn 529.10 Mn 1.62 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.62 Bn
Dec 31, 2025 1.61 Bn
Sep 30, 2025 1.58 Bn
Jun 30, 2025 1.95 Bn
Mar 31, 2025 2.13 Bn
Dec 31, 2024 1.82 Bn
Sep 30, 2024 1.86 Bn
Jun 30, 2024 1.85 Bn
Mar 31, 2024 1.80 Bn
Dec 31, 2023 1.82 Bn
Sep 30, 2023 1.82 Bn
Jun 30, 2023 1.79 Bn
Mar 31, 2023 1.75 Bn
Dec 31, 2022 1.74 Bn
Sep 30, 2022 1.71 Bn
Jun 30, 2022 1.66 Bn
Mar 31, 2022 1.61 Bn
Dec 31, 2021 1.48 Bn
Sep 30, 2021 1.49 Bn
Jun 30, 2021 1.45 Bn